Skip to main content
    A

    Akebia Ther (AKBA)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.45
    -0.03 (-5.40%)

    Market Cap: $131.67M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Akebia Ther (AKBA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Akebia Ther are Anika Therapeutics (ANIK), Cardiol Therapeutics (CRDL) and Journey Medical (DERM). By market cap, Akebia Ther ranks 7th of the 13 companies on this page; Kamada (KMDA) is the largest at $467.05M. The median P/E of the 3 companies with a P/E is 18.9x.

    Peer Comparison

    AKBA's ROIC of -38.9% is below the peer median of -3.8%, and its revenue growth of -37.2% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Akebia Ther (AKBA)$131.67MN/A0.6x-22.6%-38.9%-37.2%0.00%
    Anika Therapeutics Inc (ANIK)$179.50M18.7x1.4x-1.4%N/A10.0%0.00%
    Cardiol Therapeutics Inc Class A (CRDL)$127.69MN/AN/A0.0%N/A0.0%0.00%
    Journey Medical Corp (DERM)$122.24MN/A1.5x-7.3%-2.8%7.6%0.00%
    Organogenesis Holdings Inc (ORGO)$105.15MN/A0.3x-38.5%-66.3%-69.9%0.00%
    SIGA Technologies Inc (SIGA)$196.88M475.0xN/A1.3%N/A-49.7%0.00%
    BioAge Labs, Inc (BIOA)$255.03MN/A27.9x0.0%N/A-85.5%0.00%
    Cumberland Pharmaceuticals Inc (CPIX)$88.16MN/A3.1x148.6%N/A-74.0%28.79%
    Lifecore Biomedical Inc. (LFCR)$243.36MN/AN/A-66.8%N/A-18.6%0.00%
    OrganiGram Holdings Inc (OGI)$116.93MN/A0.4x28.0%-1.2%49.4%0.00%
    Tilray Inc (TLRY)$359.12MN/A0.3x-17.1%-4.9%22.7%0.00%
    Talphera Inc. (TLPH)$47.07MN/AN/A0.0%N/A0.0%0.00%
    Kamada (KMDA)$467.05M18.9x2.4x12.7%N/A10.7%2.10%
    Peer median$153.59M18.9x1.4x0.0%-3.8%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Akebia Ther, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    Anika Therapeutics Inc (ANIK)
    Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally.
    ANIK competitors
    Cardiol Therapeutics Inc Class A (CRDL)
    Cardiol Therapeutics Inc., a clinical-phase biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment...
    CRDL competitors
    Journey Medical Corp (DERM)
    Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
    DERM competitors
    Organogenesis Holdings Inc (ORGO)
    Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures and markets solutions for the advanced wound care and surgical and sports...
    ORGO competitors
    SIGA Technologies Inc (SIGA)
    SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health safety and infectious disease markets in the United States.
    SIGA competitors
    BioAge Labs, Inc (BIOA)
    BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United...
    BIOA competitors
    Cumberland Pharmaceuticals Inc (CPIX)
    Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development...
    CPIX competitors
    Lifecore Biomedical Inc. (LFCR)
    Lifecore Biomedical, Inc., is an integrated contract development and manufacturing organization in the United States and internationally.
    LFCR competitors
    OrganiGram Holdings Inc (OGI)
    Organigram Holdings Inc. produces and sells cannabis and cannabis-derived products in Canada. The company is headquartered in Moncton, Canada.
    OGI competitors
    Tilray Inc (TLRY)
    Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids.
    TLRY competitors
    Talphera Inc. (TLPH)
    Talphera Inc. is a pioneering biotechnology company dedicated to advancing peptide-based therapies for rare diseases and significant unmet medical needs.
    TLPH competitors
    Kamada (KMDA)
    Kamada Ltd. develops, produces and markets plasma-derived protein therapies for orphan indications. The company is headquartered in Rehovot, Israel.
    KMDA competitors

    Frequently Asked Questions About AKBA

    Who are Akebia Ther's main competitors?

    The companies most similar to Akebia Ther include Anika Therapeutics (ANIK), Cardiol Therapeutics (CRDL), Journey Medical (DERM), Organogenesis Holdings (ORGO) and SIGA Technologies (SIGA), listed from the closest match.

    Who is Akebia Ther's biggest competitor?

    Kamada (KMDA) is the largest of the similar companies at $467.05M; Anika Therapeutics (ANIK) is the closest match by business profile, size, sector and industry.

    How does AKBA stock compare with its competitors?

    AKBA's P/S is 0.6x against a peer median of 1.4x; its net margin is -22.6% against a peer median of 0.0%.

    Which of Akebia Ther's competitors pays a higher dividend?

    Akebia Ther pays no dividend. Cumberland Pharmaceuticals (CPIX) and Kamada (KMDA) have higher forward dividend yields; Cumberland Pharmaceuticals (CPIX) has the highest at 28.79%.

    Is Akebia Ther bigger than its competitors?

    No. Akebia Ther is 7th by market cap among the 13 companies on this page; the largest is Kamada (KMDA) at $467.05M.